These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18317884)

  • 21. Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression.
    Steinhauser I; Langer K; Strebhardt K; Spänkuch B
    J Drug Target; 2009 Sep; 17(8):627-37. PubMed ID: 19591537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging.
    Nurunnabi M; Cho KJ; Choi JS; Huh KM; Lee YK
    Biomaterials; 2010 Jul; 31(20):5436-44. PubMed ID: 20409581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light.
    Khullar O; Frangioni JV; Grinstaff M; Colson YL
    Semin Thorac Cardiovasc Surg; 2009; 21(4):309-15. PubMed ID: 20226343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging.
    Gao X; Chen J; Chen J; Wu B; Chen H; Jiang X
    Bioconjug Chem; 2008 Nov; 19(11):2189-95. PubMed ID: 18922029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging.
    Lee JH; Huh YM; Jun YW; Seo JW; Jang JT; Song HT; Kim S; Cho EJ; Yoon HG; Suh JS; Cheon J
    Nat Med; 2007 Jan; 13(1):95-9. PubMed ID: 17187073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo examination of (188)Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer.
    Chen KT; Lee TW; Lo JM
    Nucl Med Biol; 2009 May; 36(4):355-61. PubMed ID: 19423002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (Non-targeted) radioactive/fluorescent nanoparticles and their potential in combined pre- and intraoperative imaging during sentinel lymph node resection.
    Buckle T; Chin PT; van Leeuwen FW
    Nanotechnology; 2010 Dec; 21(48):482001. PubMed ID: 21063057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
    Lee AL; Wang Y; Cheng HY; Pervaiz S; Yang YY
    Biomaterials; 2009 Feb; 30(5):919-27. PubMed ID: 19042015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Herceptin-based therapy for breast cancer].
    Tokuda Y; Saito Y; Suzuki Y
    Nihon Rinsho; 2006 Mar; 64(3):540-5. PubMed ID: 16529047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantum dots synthesis and biological applications as imaging and drug delivery systems.
    Obonyo O; Fisher E; Edwards M; Douroumis D
    Crit Rev Biotechnol; 2010 Dec; 30(4):283-301. PubMed ID: 20528252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals.
    Erogbogbo F; Yong KT; Roy I; Hu R; Law WC; Zhao W; Ding H; Wu F; Kumar R; Swihart MT; Prasad PN
    ACS Nano; 2011 Jan; 5(1):413-23. PubMed ID: 21138323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthesis and bio-applications of magnetic and fluorescent bifunctional composite nanoparticles.
    Wang G; Su X
    Analyst; 2011 May; 136(9):1783-98. PubMed ID: 21431200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity.
    Gao J; Kou G; Wang H; Chen H; Li B; Lu Y; Zhang D; Wang S; Hou S; Qian W; Dai J; Zhao J; Zhong Y; Guo Y
    Breast Cancer Res Treat; 2009 May; 115(1):29-41. PubMed ID: 18481173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantum dots in cancer therapy.
    Luo G; Long J; Zhang B; Liu C; Ji S; Xu J; Yu X; Ni Q
    Expert Opin Drug Deliv; 2012 Jan; 9(1):47-58. PubMed ID: 22171712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies].
    Balalaeva IV; Zdobnova TA; Sokolova EA; Deyev SM
    Bioorg Khim; 2015; 41(5):599-605. PubMed ID: 26762098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy of gastric cancer.
    Ruan J; Song H; Qian Q; Li C; Wang K; Bao C; Cui D
    Biomaterials; 2012 Oct; 33(29):7093-102. PubMed ID: 22796163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marvelous applications of quantum dots.
    Cheki M; Moslehi M; Assadi M
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1141-8. PubMed ID: 23690181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice.
    Tada H; Higuchi H; Wanatabe TM; Ohuchi N
    Cancer Res; 2007 Feb; 67(3):1138-44. PubMed ID: 17283148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of HER2 Overexpressed Breast Cancer Subtype In Vivo by the Validation of High-Performance, Long-Term, and Noninvasive Fluorescence Tracer.
    Ding J; Zhou Y; Li J; Jiang L; He Z; Zhu JJ
    Anal Chem; 2015 Dec; 87(24):12290-7. PubMed ID: 26598802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging.
    Cho YS; Yoon TJ; Jang ES; Soo Hong K; Young Lee S; Ran Kim O; Park C; Kim YJ; Yi GC; Chang K
    Cancer Lett; 2010 Dec; 299(1):63-71. PubMed ID: 20826046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.